News: Momentum

Next Page »

Mutations may predict melanoma response to immunotherapies

Thursday, March 12th, 2015

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Douglas Johnson, M.D., assistant professor of Medicine, and Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, are co-first authors […]

Mining the microbiome

Saturday, December 20th, 2014

Ten-to-one. Cell for cell, they’ve got us outnumbered. And as a group, they have 100 times more genes than we do. Fortunately, these microbes that share our corporeal space are usually on our side. Known collectively as the microbiome, the microbial species that flourish along our mucosal surfaces—the linings of our intestines, mouth and nose, […]

Immune cell activity and melanoma

Thursday, November 6th, 2014

Melanoma, the most lethal form of skin cancer, spreads aggressively and is often resistant to therapy. Melanoma tumor formation is driven in part by nuclear factor-kappa B (NF-kappaB)-mediated gene transcription, and loss of NF-kappaB activity can block melanoma tumor formation. However, NF-kappaB also plays a crucial role in immune cells. In an October online edition […]

Opening Pandora’s Box

Monday, July 2nd, 2012

It’s been two years since Joan Meredith’s stem cell transplant for acute myeloid leukemia (AML). Although she is now “100 percent donor” and her new immune system appears to be functioning well, she remains vigilant against the health complications related to her transplant – like infections, for example. “I hated wearing the mask because I […]

Dayani Center Ready to Help Smokers Quit

Friday, November 11th, 2011

Barbara Forbes, MSN, keeps a big jar of tar on her desk. The dark, goopy mess is a visual representation of the amount of tar that a smoker will ingest by smoking one pack of cigarettes per day for a year. Forbes is the director of the Smoking Cessation Institute at the Vanderbilt Dayani Center […]

Decision Tree

Wednesday, June 22nd, 2011

Kort Nygard opted to wait until his prostate cancer needed treatment. Then he decided to have open surgery. Jim Davidson chose radiation therapy, the external beam type. Sam Dick selected robotic surgery. Three different patients with prostate cancer, three different treatment choices. The decision that faces a man diagnosed with localized prostate cancer is daunting. […]

Moving On

Wednesday, June 22nd, 2011

Susan Hahn is moving again – into a new home and into a new stage of life after cancer. The Chicago native had moved to Nashville in January 2009. She was engaged by that July and quickly began planning a big wedding. She and her fiancé had also just begun plans to tear down and […]

Keeping Up With Cancer

Wednesday, June 22nd, 2011

The long-term forecast for the fight against cancer is indeed gloomy if a predicted shortage of oncologists comes to pass. The impending shortage, predicted recently by a study commissioned by the American Society of Clinical Oncology (ASCO), could result in a shortage of as many as 4,000 oncologists by 2020, causing cancer patients to travel […]

Divide And Conquer

Wednesday, June 22nd, 2011

When the United States declared a “War on Cancer” 40 years ago, the endeavor was envisioned as a strategic battle, with doctors and researchers employing overwhelming force and lethal technology in a straightforward march to victory against a disease that claimed millions of lives. Scientists have made progress in the ensuing years, yet the enemy […]

Big Picture Moments

Wednesday, June 22nd, 2011

As a clinical trials nurse Wendy Cooper, B.S.N., R.N., has a ringside seat to the bench-to-bedside progress of cancer research. “We have brilliant minds who work on one pathway or one piece of the puzzle for their entire career,” said Cooper, the assistant director of clinical research operations for the Clinical Trials Shared Resource (CTSR) […]